dc.contributor.author | Sonmezoglu, K. | |
dc.contributor.author | Halac, M. | |
dc.contributor.author | Sayman, H. B. | |
dc.contributor.author | Sager, S. | |
dc.contributor.author | Asa, S. | |
dc.contributor.author | Vatankulu, B. | |
dc.contributor.author | Aksoy, S. Yilmaz | |
dc.date.accessioned | 2021-03-05T19:46:12Z | |
dc.date.available | 2021-03-05T19:46:12Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Vatankulu B., Aksoy S. Y. , Asa S., Sager S., Sayman H. B. , Halac M., Sonmezoglu K., "Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes", REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, cilt.35, ss.17-21, 2016 | |
dc.identifier.issn | 2253-654X | |
dc.identifier.other | av_d0d1c018-39ae-4323-8669-4a3437f908e8 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/138043 | |
dc.identifier.uri | https://doi.org/10.1016/j.remn.2015.07.001 | |
dc.description.abstract | Objective: There is still no consensus about whether to perform PET/CT to detect carcinoma in paraneoplastic neurological syndromes (PNS) in patients with or without antibodies. The aim of this study is to determine the diagnostic accuracy of PET/CT and antibodies in patients with PNS. | |
dc.language.iso | eng | |
dc.subject | Nükleer Tıp | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | RADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME | |
dc.title | Accuracy of FDG-PET/CT and paraneoplastic antibodies in diagnosing cancer in paraneoplastic neurological syndromes | |
dc.type | Makale | |
dc.relation.journal | REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 35 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 17 | |
dc.identifier.endpage | 21 | |
dc.contributor.firstauthorID | 228179 | |